FAB Insider Trading

Insider Ownership Percentage: 10.37%
Insider Buying (Last 12 Months): £9,840.75
Insider Selling (Last 12 Months): GBX 0

Fusion Antibodies Insider Trading History Chart

This chart shows the insider buying and selling history at Fusion Antibodies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Fusion Antibodies Share Price & Price History

Current Price: GBX 3.40
Price Change: Price Decrease of -0.05 (-1.45%)
As of 05/17/2024 01:00 AM ET

This chart shows the closing price history over time for FAB up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Fusion Antibodies Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/4/2023Simon Gordon DouglasInsiderBuy100,565GBX 5£5,028.25
6/9/2023Richard John BuickInsiderBuy68,750GBX 7£4,812.50
10/31/2022Sonya Maria FergusonInsiderBuy10,000GBX 42£4,200
9/20/2022Adrian KinkaidInsiderBuy4,000GBX 54£2,160
See Full Table

SEC Filings (Institutional Ownership Changes) for Fusion Antibodies (LON:FAB)

24.43% of Fusion Antibodies stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Fusion Antibodies logo
Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. It serves pharmaceutical, biotech, and diagnostic companies. The company has a collaboration partnership with Celonic AG. The company was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
Read More on Fusion Antibodies

Today's Range

Now: GBX 3.40
Low: 3.23
High: 3.47

50 Day Range

MA: GBX 3.74
Low: 3.24
High: 4.18

52 Week Range

Now: GBX 3.40
Low: 3.02
High: 36

Volume

337,591 shs

Average Volume

1,100,455 shs

Market Capitalization

£3.24 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.44

Who are the company insiders with the largest holdings of Fusion Antibodies?

Fusion Antibodies' top insider investors include:
  1. Adrian Kinkaid (Insider)
  2. Richard John Buick (Insider)
  3. Simon Gordon Douglas (Insider)
  4. Sonya Maria Ferguson (Insider)
Learn More about top insider investors at Fusion Antibodies.